Publicaciones en colaboración con investigadores/as de University of Münster (13)

2023

  1. A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets

    Neurodegenerative Disease Management, Vol. 13, Núm. 1, pp. 15-21

  2. Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary

    Neurodegenerative Disease Management, Vol. 13, Núm. 1, pp. 5-13

  3. Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence

    Multiple Sclerosis and Related Disorders, Vol. 69

2022

  1. Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data

    Multiple Sclerosis Journal, Vol. 28, Núm. 5, pp. 842-846

  2. Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial

    European Journal of Neurology, Vol. 29, Núm. 3, pp. 790-801

  3. The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

    Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 28, Núm. 9, pp. 1424-1456

  4. Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis

    Multiple Sclerosis Journal

2021

  1. Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice

    Therapeutic Advances in Neurological Disorders, Vol. 14

2015

  1. Comparative efficacy of switching to natalizumab in active multiple sclerosis

    Annals of Clinical and Translational Neurology, Vol. 2, Núm. 4, pp. 373-387

  2. Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e147

2014

  1. Clinical relevance of brain volume measures in multiple sclerosis

    CNS Drugs, Vol. 28, Núm. 2, pp. 147-156

  2. Specific aspects of modern life for people with multiple sclerosis: Considerations for the practitioner

    Therapeutic Advances in Neurological Disorders, Vol. 7, Núm. 2, pp. 137-149

2011

  1. Symptomatic therapy in multiple sclerosis: A review for a multimodal approach in clinical practice

    Therapeutic Advances in Neurological Disorders, Vol. 4, Núm. 3, pp. 139-168